NASDAQ: MYOK       Myokardia Inc
Last Price Today's Change   Day's Range   Trading Volume
130.23   -6.33 (4.64%)  128.467 - 137.84  37,432


Avg Volume (4 weeks):442,652
4 Weeks Range:98.57 - 137.84
4 Weeks Price Volatility (%):
52 Weeks Range:42.65 - 137.84
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

MyoKardia Inc is a US-based clinical-stage biopharmaceutical company which is engaged in discovering, developing and commercializing targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. The company mainly focuses on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. It uses its medicine platform to generate an initial pipeline of therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy—hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy. The company’s products include MYK-461 s an orally administered small molecule to reduce excessive cardiac muscle contractility leading to HCM.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1159  4489  509  3130 

Top 10 Active Counters
 LK 1.38+1.38 
 AVP 5.60-0.05 
 AABA 19.630.00 
 TGE 22.39+0.81 
 APY 10.34+0.25 
 ONTX 0.426+0.104 
 AKRX 0.09-0.094 
 PGNX 4.10-0.425 
 XOG 0.271-0.062 
 TUES 0.2820.00